TERUMO INTERVENTIONAL SYSTEMS

Telumo Gloabal
Ultimaster™
Ultimaster™ Tansei™
Contact
EMEA
APAC
Latin America
Clinical Evidence
CENTURY II Bifurcation sub-group
CENTURY II Multivessel disease
CENTURY II Total population
DISCOVERY 1TO3
e-Ultimaster Bifurcation sub group
e-Ultimaster Left Main sub group
e-Ultimaster Total population
MASTER DAPT
MODEL U-SES

S0_Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

S0_Ready to get started? Sign up now!

S0_Lorem ipsum dolor sit amet

S0_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

S0_Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

PICKUPS
[May in 2022] Left main and complex bifurcation PCI in HBR patients - TNT in EuroPCR 2022 >>>
[May in 2022] Trans-radial approach, from complex PCI to peripheral intervention - TNT in EuroPCR 2022 >>>
[Mar in 2022] MASTER CLASS - DAPT Practice in Asia Pacific - Terumo Asia Pacific Webinar  >>>
[Jan in 2022]  Navigating Through Complex Lesions in PCI - SingLive 2022  >>>
[Aug in 2021] MASTER DAPT Clinical Study at a Glance - ESC  >>>
[Nov in 2021] Outcomes in HBR Patients with High Thrombotic and Ischemic Risk? - TCT 2021 LBT >>>

 

S1_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

S1_2-Col, Left Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

  • Many addon features
  • Fully responsive & adaptive
  • SEO optimized
  • Attractive with a modern touch
  • Full Support

S1_Ut Enim Minima

Sed ut perspiciatis unde omnis iste natus error sit voluptatem!

Quis Autem Vel

Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!

Quo Voluptas

Ut enim ad minima veniam, quis nostrum exercitationem ullam!

S1_Consectetur adipiscing elit...

Joanna C.

"Et harum quidem rerum facilis est et expedita distinctio!"

Stanley T.

"Nam libero tempore, cum soluta nobis est eligendi."

Danielle W.

"Temporibus autem quibusdam et aut officiis debitis!"

S1_Lorem ipsum dolor sit amet

Webinar Information

 Left main and complex bifurcation PCI in high bleeding risk patients

Event: Tools and Techniques in EuroPCR 2022/ May 17-20, 2022 / Paris, France and Online

Anchorperson: T. Cuisset
Moderator: G.G. Toth
Discussants: F. Burzotta, M. Lesiak
Operators: P. Garot, T. Lefèvre, Y. Onuma
Medical Control Desk: E. Asher

 Watch the webinar
Session objectives:
- To appreciate the value of transradial approach for left main and complex bifurcation PCI
- To acknowledge Ultimaster DES results in bifurcations and high bleeding risk patients
- To understand how to optimise strategy and technique using intra-coronary imaging (optical frequency domain imaging)
 
 to the TOP



 Trans-radial approach, from complex PCI to peripheral intervention

Event: Tools and Techniques in EuroPCR 2022/ May 17-20, 2022 / Paris, France and Online

Anchorperson: J. Fajadet
Moderator: S. Kedev
Discussants: A. Aminian, M. Roffi

 Watch the Webinar
Session objectives:
- To demonstrate how to optimise challenging coronary and peripheral cases using dedicated devices in transradial approach
- To appreciate the value of transradial approach for complex PCI and carotid artery stenting
- To acknowledge Ultimaster DES results in high bleeding risk patient population
 
 to the TOP



Master Class -DAPT Practice in Asia Pacific-

Event: Master Class Webinar /Mar 19, 2022, 14:30-16:45 (GMT+8) / Hybrid

 btn-watch-the-webinar.png
(Free registration)
Through this discussion, you can…
- Address key concerns surrounding HBR DAPT management
- Draw clarity and confidence from clinical evidence on short DAPT
- Gain practical advice on DAPT practice change from regional experts

 
 to the TOP



 Navigating Through Complex Lesions in PCI

Event: Singapore LIVE 2022 ONLINE / Jan 21, 2022, 11:00-11:55 (SGT) / Online

 Go to the site
(Free registration)
Session objectives:
- To discuss different types of complex lesions can be encountered in PCI.
- To understand the differences between MASTER DAPT and other DAPT trials.
- To understand how Ultimaster Tansei can benefit HBR patients through case sharing.
- To understand how ACIST FFR and Ultimaster Tansei can simplify complex PCI.
icon-download-document.png     You can download a flyer of the event.
 
 to the TOP



 MASTER DAPT Clinical Study at a Glance
Event: ESC (European Society of Cardiology) / Aug, 2021 / Europe  Watch the video
Contents:
Get an overview of the MASTER DAPT study in this interview with principle investigator of MASTER DAPT trial, Dr. Marco Valgimigli, talking at ESC 2021. Watch the interview to learn about the study design and primary endpoints, evidence of the non-inferiority of short DAPT, and how to apply the results to your clinical practice.  
 
 to the TOP



 Outcomes in High Bleeding Risk Patients with High Thrombotic and Ischemic Risk
Event: TCT 2021 LBT (Transcatheter Cardiovascular Therapeutics) / Nov, 2021 / US
 Register to watch

Contents:
Find out more about the results from the subgroup analysis of the MASTER DAPT study and how the results bridge the current knowledge gap on DAPT duration in HBR patients in this presentation by Dr. Pieter C. Smits, principle investigator of MASTER DAPT study, from TCT 2021.
Watch the webinar to gain new insights into clinical outcomes for high bleeding risk patients with high thrombotic and ischemic risks, and discover how the results can help you select the optimal DAPT strategy for your patients.
Register free with TCTMD to access the video.

 
 to the TOP
 The Unknown HBR Patient: Deep Dive into DAPT durations for HRB Patients
Event: DAPT meets its MASTER in Incathlab Webinar (Media) / Nov, 2021 / Europe
 Register to watch
Contents:
In this conversation between three European experts, learn how to master the latest data on HBR patients and DAPT duration, the potential impact the study has on clinical practices, and how you can put the evidence for short DAPT with HBR patients into practice, as they discuss the MASTER DAPT study and HBR cases.
Register free with Incathlab to watch.
 
 to the TOP



 MASTER DAPT Outcomes - Panel Discussion
Event: AICT-AsiaPCR2021 / Oct, 2021 / Asia Pacific
 Watch the webinar
Contents:
In this panel session dedicated to the study, learn more about the results of MASTER DAPT, what it means to patients and doctors, and how the clinical evidence proving the non-inferiority of short DAPT to standard could potentially impact the guidelines for DAPT duration in HBR patients.
 
 to the TOP



 Practical Applications of MASTER DAPT at Japan's Leading Hospital
Event: East Asia PCI MASTER2021 - The Management of HBR patients / Oct, 2021 / Hong Kong & Taiwan
 Watch the webinar
Contents:
Learn how to implement an optimized DAPT protocol for HBR patients in this lecture by Dr. Takashi Muramatsu. Dr Muramatsu is based at Fujita Health University Hospital, where the designed a short DAPT protocol for HBR patients based on the positive outcomes of the MASTER DAPT trial. 
 
 to the TOP


 

img-product-ultimaster-600x400.png

Ultimaster

Design ensuring better biocompatibility for long-term safety.
 ・Long term efficacy and safety proven by RCT in patients with complex background. 
 ・Early healing by abluminal gradient coating and reduced drug dose.
 ・Reliable long-term patency by stronger vessel support and fracture resistance.   .... more

img-product-ultimastertansei-600x400.png

Ultimaster Tansei

Cross challenging anatomy with confidence. Advanced shaft technology for outstanding acute performance. Track complex lesions with ease. A tip designed to facilitate treatment of the most challenging cases.
・Updated exit port - smooth and balanced transition
Advanced shaft technology - good transmission force and pushability, excellent kink resistance
Innovative tip - Optimized durability and clear visibility  ...more

S2_Ut Enim Minima

Sed ut perspiciatis unde omnis iste natus error sit voluptatem!

Quis Autem Vel

Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!

Quo Voluptas

Ut enim ad minima veniam, quis nostrum exercitationem ullam!

S2_Consectetur adipiscing elit...

Joanna C.

"Et harum quidem rerum facilis est et expedita distinctio!"

Stanley T.

"Nam libero tempore, cum soluta nobis est eligendi."

Danielle W.

"Temporibus autem quibusdam et aut officiis debitis!"

S2_Lorem ipsum dolor sit amet

S3_Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

S3_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

S3_2-Col, Left Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

  • Many addon features
  • Fully responsive & adaptive
  • SEO optimized
  • Attractive with a modern touch
  • Full Support

S3_Ut Enim Minima

Sed ut perspiciatis unde omnis iste natus error sit voluptatem!

Quis Autem Vel

Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!

Quo Voluptas

Ut enim ad minima veniam, quis nostrum exercitationem ullam!

S3_ Consectetur adipiscing elit...

Joanna C.

"Et harum quidem rerum facilis est et expedita distinctio!"

Stanley T.

"Nam libero tempore, cum soluta nobis est eligendi."

Danielle W.

"Temporibus autem quibusdam et aut officiis debitis!"

S3_Lorem ipsum dolor sit amet

S4_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

S4_Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

S4_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

Customer support

At TERUMO, we don´t just deliver quality medical products – we offer the resources and support necessary for them to be used to their full potential. Contact us today for any assistance you may need.